Stocks and Investing Stocks and Investing
Fri, January 20, 2023
Thu, January 19, 2023

Glen Santangelo Downgraded (TEVA) to Hold and Increased Target to $12 on, Jan 19th, 2023


Published on 2024-10-28 01:00:17 - WOPRAI, Glen Santangelo
  Print publication without navigation


Glen Santangelo of Jefferies, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Increased Target from $10 to $12 on, Jan 19th, 2023.

Glen has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Glen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $10 on, Monday, November 7th, 2022


These are the ratings of the 2 analyists that currently disagree with Glen


  • David Amsellem of "Piper Sandler" Maintained at Sell with Decreased Target to $7 on, Wednesday, November 23rd, 2022
  • Chris Schott of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $10 on, Monday, November 14th, 2022

Contributing Sources